rts logo

Positives for NewAmsterdam Pharma Company NV (NAMS) as stock gains in recent trading

NewAmsterdam Pharma Company NV (NASDAQ: NAMS) is -13.27% lower on its value in year-to-date trading and has touched a low of $15.19 and a high of $27.29 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NAMS stock was last observed hovering at around $21.77 in the last trading session, with the day’s gains setting it 0.52%.

Currently trading at $22.29, the stock is -6.40% and -4.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.33 million and changing 2.39% at the moment leaves the stock 11.93% off its SMA200. NAMS registered 11.79% gain for a year compared to 6-month gain of 30.20%. The firm has a 50-day simple moving average (SMA 50) of $23.3 and a 200-day simple moving average (SMA200) of $19.913574.

The stock witnessed a -12.93% loss in the last 1 month and extending the period to 3 months gives it a 17.50%, and is -5.55% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.02% over the week and 4.84% over the month.

Distance from 52-week low is 46.74% and -18.32% from its 52-week high.

with sales reaching $1.67M over the same period.The EPS is expected to grow by 5.52% this year, but quarterly earnings will post 138.76% year-over-year.

NewAmsterdam Pharma Company NV (NAMS) Top Institutional Holders

143.0 institutions hold shares in NewAmsterdam Pharma Company NV (NAMS), with institutional investors hold 87.36% of the company’s shares. The shares outstanding are 92.17M, and float is at 60.55M with Short Float at 4.94%. Institutions hold 87.04% of the Float.

NewAmsterdam Pharma Company NV (NAMS) Insider Activity

#####

Still, SEC filings show that on Jan 10 ’25, NAP PoolCo B.V. (Affiliate) Proposed Sale 1,396,241 shares at an average price of $25.31 for $35.34 million. The insider now directly holds shares of NewAmsterdam Pharma Company NV (NAMS).

Related Posts